Selection of optimal sites for TGFB1 gene silencing by chitosan–TPP nanoparticle-mediated delivery of shRNA
Authors:
- Zheng-Hong QinZQZheng-Hong Qin
- 1 April 2009
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 190 (1) , 8-14
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A delicate balance: TGF‐β and the tumor microenvironmentJournal of Cellular Biochemistry, 2007
- Inhibition of Transforming Growth Factor-β Signaling in Human Cancer: Targeting a Tumor Suppressor Network as a Therapeutic StrategyClinical Cancer Research, 2006
- Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vectorEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- The use of chitosan as a condensing agent to enhance emulsion-mediated gene transferBiomaterials, 2005
- Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behaviorJournal of Colloid and Interface Science, 2005
- RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates TumorigenicityIn vivoCancer Research, 2004
- The RNAi revolutionNature, 2004
- The two faces of transforming growth factor β in carcinogenesisProceedings of the National Academy of Sciences, 2003
- Systematic analysis of the TGF‐β/Smad signalling pathway in the rhabdomyosarcoma cell line RDInternational Journal of Experimental Pathology, 2003
- The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug releaseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2002